ACL Digital, a global leader in digital product innovation and engineering services, has announced the acquisition of Symbiance, a data-driven, technology-enabled Contract Research Organization (CRO) with over three decades of proven expertise in clinical data services and operations, medical monitoring, project management, medical writing, and pharmacovigilance segments. The acquisition of Symbiance by ACL Digital solidifies its position as an end-to-end provider of clinical research and data CRO solutions on a global scale. It also strengthens ACL Digital’s overall Life Sciences portfolio by integrating deep domain expertise in clinical data management, data standardization, biostatistics, statistical programming, medical writing and pharmacovigilance.
Read the full article: ACL Digital Acquires a US-based CRO, Symbiance, to Expand and Scale Its Clinical Research Capabilities //
Source: https://www.prnewswire.com/news-releases/acl-digital-acquires-a-us-based-cro-symbiance-to-expand-and-scale-its-clinical-research-capabilities-302565756.html